Natera Inc (NTRA): Market Cap to Revenue Ratio

Symbol and logo of brand Natera Corp (NTRA)

Demand for diagnostics is overloading laboratory capacities, necessitating the robotization of processes. The linear chart of the industry-average P/S for Natera, Inc. (NTRA) on GURU.Markets confirms this growth, with the metric holding at 15.80. This price action is supported by the integration of Signatera into insurance standards and high margins driven by software-based DNA analysis, which allows for the seamless scaling of testing volumes.

Market Cap to Revenue: Natera Medical (NTRA) for 07/04/2022 - 11/14/2026

Metric breakdowns and analytics for Natera Corp (NTRA)

- stock price and consensus target price:
Share Price natera.com|NTRA - Price Target Chart
- stock exchange capitalization data:
Market Capitalization Natera Corp|NTRA - Enterprise Value
- business book valuation details:
Book Value per Share Natera|NTRA - Company Net Assets|Market Cap to Book Value Multiple natera.com|NTRA - Company Total Assets
- debt obligations and liquidity statistics:
Debt to Capital Natera, Inc.|NTRA - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Natera Medical|NTRA - Company Aggregate Debts|Debts to Book Capitalization Natera Corp|NTRA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Natera|Interim Coverage Ratio natera.com
- company profitability and valuation multiples indicators:
NTRA - Company Net Income|Net Profit Forecast Natera, Inc.|NTRA - P/E Multiple|Projected Price to Earnings Natera Inc|NTRA - Price/Earnings to Growth Multiple|Total Company Value to Operating Income Before Depreciation Ratio Natera Corp|NTRA - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Natera|NTRA - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months natera.com|NTRA - Earnings per share growth in current year|Expected earnings per share trend next year Natera, Inc.
- sales revenue and business income indicators:
NTRA - Revenue and Sales Volume|Projected Sales Volume natera.com|NTRA - Price-to-Revenue Ratio|Forward Price to Sales Natera Corp
General company analysis:NTRA natera.com
Mass-produced product of Natera Medical

Investors assess an asset's operational efficiency through the price-to-sales ratio, where the price-to-sales multiple demonstrates the market's willingness to pay a premium for each unit of revenue. For Natera, Inc. (NTRA), whose dominance in non-invasive genetics guarantees stable demand from clinics, this indicator confirms the business's premium status, balancing a high market valuation with the actual resilience of its cash flows.

Who Natera, Inc. competes with

humacyte.com - Market Cap to Revenue Ratio|Price-to-Revenue Ratio Sera Prognostics SERA